The Effect of Intensive Dietary Intervention on the Level of RANTES and CXCL4 Chemokines in Patients with Non-obstructive Coronary Artery Disease: A Randomised Study

• Main Authors: Magdalena Makarewicz-Wujec, Jan Henzel, Mariusz Kruk, Cezary Kępka, Łukasz Wardziak, Piotr Trochimiuk, Andrzej Parzonko, Marcin Demkow, Zofia Dzielińska, Malgorzata Kozłowska-Wojciechowska
• Format: Article
• Language: English
• Published: MDPI AG 2021-02-01
• Series: Biology
• Subjects: DASH diet; chemokine CXCL4; chemokine RANTES; atherosclerosis; inflammation
• Online Access: https://www.mdpi.com/2079-7737/10/2/156

Background: Inflammation is the key pathophysiological mechanism of the initiation and progression of atherosclerosis. The study objective was to assess the effects of a dietary intervention based on the model of the dietary approaches to stop hypertension (DASH) diet on the levels of chemokines RANTES and CXCL4 in patients with non-obstructive coronary artery disease. Methods: As part of Dietary Intervention to Stop Coronary Atherosclerosis in Computed Tomography (DISCO-CT) study, patients were randomised to an intervention group (<i>n</i> = 40), where the DASH diet was introduced along with optimal pharmacotherapy, and to a control group (<i>n</i> = 39), with optimal pharmacotherapy alone. In the DASH group, systematic dietary counselling was provided for the follow-up period. RANTES and CXCL4 levels were determined using ELISA. Results: In the DASH group, the RANTES level insignificantly reduced from 42.70 ± 21.1 ng/ml to 38.09 ± 18.5 ng/ml (<i>p</i> = 0.134), and the CXCL4 concentration significantly reduced from 12.38 ± 4.1 ng/mL to 8.36 ± 2.3 ng/mL (<i>p</i> = 0.0001). At the same time, an increase in the level of both chemokines was observed in the control group: RANTES from 34.69 ± 22.7 to 40.94 ± 20.0 ng/mL (<i>p</i> = 0.06) and CXCL4 from 10.98 ± 3.6 to 13.0 5± 4.8 ng/ml (<i>p</i> = 0.009). The difference between the changes in both groups was significant for both RANTES (<i>p</i> = 0.03) and CXCL4 (<i>p</i> = 0.00001). The RANTES/CXCL4 ratio reduced in the control group (from 3.52 ± 2.8 to 3.35 ± 2.8; <i>p</i> = 0.006), while in the DASH group, an increase was observed (from 3.54 ± 1.7 to 4.77 ± 2.4; <i>p</i> = 0.001). Conclusions: A 12-month-long intensive dietary intervention based on DASH diet guidelines as an addition to optimal pharmacotherapy causes changes in the levels of chemokines CXCL4 and RANTES and their mutual relationship in comparison to conventional treatment.